Your browser doesn't support javascript.
loading
Real-world use of pemigatinib for the treatment of cholangiocarcinoma in the US.
Saverno, Kim; Zimmerman Savill, Kristin M; Brown-Bickerstaff, Cherrishe; Kotomale, Angele; Rodriguez, Michael; Feinberg, Bruce; Ren, Haobo; Blecker, Mike; Kim, Richard.
Affiliation
  • Saverno K; Incyte Corporation, Wilmington, DE, United States.
  • Zimmerman Savill KM; Cardinal Health, Real-World Evidence and Insights, Dublin, OH, United States.
  • Brown-Bickerstaff C; Cardinal Health, Real-World Evidence and Insights, Dublin, OH, United States.
  • Kotomale A; Cardinal Health, Real-World Evidence and Insights, Dublin, OH, United States.
  • Rodriguez M; Incyte Corporation, Wilmington, DE, United States.
  • Feinberg B; Cardinal Health, Real-World Evidence and Insights, Dublin, OH, United States.
  • Ren H; Incyte Corporation, Wilmington, DE, United States.
  • Blecker M; Incyte Corporation, Wilmington, DE, United States.
  • Kim R; Department of Gastrointestinal Oncology, Moffitt Cancer Center, Tampa, FL, United States.
Oncologist ; 2024 Aug 21.
Article in En | MEDLINE | ID: mdl-39173023
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Oncologist Journal subject: NEOPLASIAS Year: 2024 Document type: Article Affiliation country: United States Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Oncologist Journal subject: NEOPLASIAS Year: 2024 Document type: Article Affiliation country: United States Country of publication: United kingdom